What Is Product Recall Expense Insurance for a Medical Device Company?

Product recall expense insurance pays the direct costs of executing a recall on a medical device. Notification to distributors, hospitals, providers, and patients. Retrieval of units from the field. Replacement or rework of the affected product. Disposal of returned units. Business interruption while the recall is underway. It is a first-party coverage, paying the manufacturer for its own costs, and it is structurally different from products liability, which pays third-party bodily-injury claims arising from units used before the recall. Most device companies carry one of the two and not the other, and the gap surfaces exactly when a recall is announced.

Two Lines, Two Different Costs

A recall produces two separate streams of cost. The first stream is the cost of doing the recall itself: identifying which units are affected, locating where they are, communicating with every party in the chain, getting the units back, replacing or remediating them, and absorbing the lost revenue while the affected product is off the market. This is the first-party side, the manufacturer’s own expense, and product recall expense insurance is the line that pays it.

The second stream is the cost of harm caused by units already in use when the safety issue surfaced. A patient injured by a unit that was implanted, used clinically, or otherwise put in service before the recall files a claim. That claim is third-party bodily injury, and it routes through products liability for the device, not through the recall expense line. The two policies cover the same event from two different angles, and the wording on each form addresses different costs.

Why Companies Carry One Without the Other

The most common pattern is products liability without recall expense. The carrier writing products may include a small recall expense sub-limit inside the products policy, often in the low six figures, and the company reads that as recall coverage. It is not, in any meaningful sense, recall coverage for a real Class II or Class III recall. The cost of executing a recall on units in the field across multiple hospitals or distributors runs well beyond what a sub-limit in a products policy was sized for, and the recall-as-sub-limit pattern is the structural gap that most often goes undiscovered until the FDA-coordinated recall is underway and the bills start arriving.

The reverse pattern (recall expense without products liability) is rare in the device segment because products is almost always the first line a manufacturer carries. The pattern that does occur is products liability with an inadequately sized recall expense line that was bought as an afterthought rather than calibrated to the actual recall exposure.

What a Real Recall Costs (Categorically)

A device recall is a sequence of operational steps under FDA oversight. The categories that drive cost include notification of every party in the distribution chain on the timeline the FDA mandates, physical retrieval of units with chain-of-custody documentation, replacement or remediation of affected units, disposal of returned units that cannot be remediated, lost revenue while the product is off the market, and reputational rehabilitation. A recall expense policy is sized against the realistic total of those categories for the company’s actual unit count, not against a generic sub-limit.

The recall expense line also addresses business interruption from the recall itself. Revenue from the affected product stops the day the recall is announced, and the cost of that interruption can rival the direct expenses. The fuller commercial-stage picture sits in Class II device insurance before commercialization, and the recall-coverage basics for Class II are mapped in recall coverage for Class II device manufacturers.

How the Two Lines Coordinate

The dovetail with products liability matters because the same event triggers both. A safety issue that produces a recall almost always produces some downstream third-party claims, and the program has to answer both the first-party expense of the recall itself and the third-party claims that follow it. A program with strong products limits and a weak recall expense line is exposed on the first-party side; the inverse exposure is on the third-party side. Sizing each independently against the realistic exposure for that specific category is the practical fix.

A connected device adds a cyber-rooted recall question, where a vulnerability under Section 524B can trigger a recall on top of the products liability and cyber exposure. The recall expense line and the cyber policy need to coordinate so a cyber-rooted recall does not fall into a gap, the kind of seam mapped in products liability for medical device manufacturers and the 524B cybersecurity requirements.

What to Do Now

Before commercialization or at renewal, separate the two cost streams a recall would actually produce: the first-party expense of executing the recall (notification, retrieval, replacement, disposal, business interruption) and the third-party bodily-injury claims from units already in use. Confirm a discrete recall expense line answers the first stream, sized to the realistic recall scenario for the company’s unit count and distribution footprint, rather than relying on a sub-limit inside the products policy. Confirm the products line answers the second stream at limits appropriate to the indication and patient population.

The fix is structural, not transactional. A specialty review through Tower Street Insurance can confirm a device company’s recall expense and products liability lines are sized independently against the recall scenario the company would actually face, rather than assumed to overlap.